Bank of New York Mellon’s Precision BioSciences DTIL Stock Holding History

Bank of New York Mellon’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$467K	Buy	+59,387	New	+$418K	﹤0.01%	3787
2024 Q1	–	Sell	-846	Closed	-$9.26K	–	4203
2023 Q4	$9.26K	Hold	846	–	–	﹤0.01%	4270
2023 Q3	$8.66K	Hold	846	–	–	﹤0.01%	4306
2023 Q2	$13.3K	Sell	846 -187	-18%	-$4.28K	﹤0.01%	4325
2023 Q1	$23.4K	Hold	1,033	–	–	﹤0.01%	4292
2022 Q4	$36.9K	Sell	1,033 -2	-0.2%	-$79	﹤0.01%	4280
2022 Q3	$40K	Hold	1,035	–	–	﹤0.01%	4355
2022 Q2	$50K	Sell	1,035 -5,067	-83%	-$297K	﹤0.01%	4341
2022 Q1	$564K	Buy	6,102 +166	+3%	+$22.6K	﹤0.01%	3638
2021 Q4	$1.32M	Buy	5,936 +173	+3%	+$48.3K	﹤0.01%	3232
2021 Q3	$2M	Buy	5,763 +788	+16%	+$267K	﹤0.01%	2975
2021 Q2	$1.87M	Sell	4,975 -824	-14%	-$247K	﹤0.01%	3025
2021 Q1	$1.8M	Sell	5,799 -363	-6%	-$127K	﹤0.01%	2978
2020 Q4	$1.54M	Buy	6,162 +394	+7%	+$96.6K	﹤0.01%	2990
2020 Q3	$1.07M	Buy	5,768 +303	+6%	+$60.3K	﹤0.01%	3095
2020 Q2	$1.36M	Buy	5,465 +2,143	+65%	+$469K	﹤0.01%	2925
2020 Q1	$601K	Buy	3,322 +266	+9%	+$69.6K	﹤0.01%	3259
2019 Q4	$1.27M	Buy	3,056 +1,940	+174%	+$610K	﹤0.01%	3105
2019 Q3	$281K	Buy	1,116 +457	+69%	+$149K	﹤0.01%	3801
2019 Q2	$262K	Buy	+659	New	+$265K	﹤0.01%	3846

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon's DTIL Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Precision BioSciences (DTIL) in Q2 2026: 59,387 shares worth $467K. The stake represents ﹤0.01% of the portfolio and ranks #3787 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in DTIL as recently as Q4 2023.

Bank of New York Mellon first reported a position in DTIL in Q2 2019 and has held it in 20 quarters since. The position peaked at $2M in Q3 2021. 41 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Bank of New York Mellon held 59,387 shares of Precision BioSciences worth $467K as of Q2 2026.
Precision BioSciences was a new Bank of New York Mellon position in Q2 2026.
Precision BioSciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3787 holding.
Bank of New York Mellon first reported a position in Precision BioSciences in Q2 2019 and has held it in 20 quarters since.
Bank of New York Mellon's Precision BioSciences position peaked at $2M in Q3 2021.
41 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.